Related Experiment Video
Updated: Jul 19, 2026

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
Published on: March 28, 2021
2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents
Jang-Yang Chang1, Ming-Fang Yang, Chi-Yen Chang
1Institute of Cancer Research, National Health Research Institutes, Taipei 114, Taiwan.
Abstract:
A novel series of 2-amino and 2'-aminocombretastatin derivatives were synthesized and evaluated for antitumor activity. Several compounds had excellent antiproliferative activity as inhibitors of tubulin polymerization. Compounds 11, 20, and 21 with IC(50) values of 1.6, 1.7, and 1.8 microM, respectively, exhibited more potent inhibition of tubulin polymerization than colchicine and approximately as active as combretastatin A-4. They also displayed antiproliferative activity with an IC(50) values ranging from 11 to 44 nM in a variety of human cell lines from different organs. Structure activity relationship information suggests that the NH(2) substituent at the 2-position of either ring A or ring B in combretastatin molecular skeleton may play an important role in the bioactivity of this series of compounds.
Related Concept Videos
Drugs that Destabilize Microtubules
Anthelminthic Agents
Drugs that Stabilize Microtubules
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Antifungal Agents
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists